Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Short-term Investments (2022 - 2025)

Historic Short-term Investments for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Q3 2025 value amounting to $408.3 million.

  • Day One Biopharmaceuticals' Short-term Investments rose 20106.84% to $408.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $408.3 million, marking a year-over-year increase of 20106.84%. This contributed to the annual value of $406.8 million for FY2024, which is 20004.65% up from last year.
  • Latest data reveals that Day One Biopharmaceuticals reported Short-term Investments of $408.3 million as of Q3 2025, which was up 20106.84% from $417.5 million recorded in Q2 2025.
  • Day One Biopharmaceuticals' Short-term Investments' 5-year high stood at $439.7 million during Q1 2025, with a 5-year trough of $47.6 million in Q1 2024.
  • For the 4-year period, Day One Biopharmaceuticals' Short-term Investments averaged around $254.7 million, with its median value being $253.7 million (2023).
  • Per our database at Business Quant, Day One Biopharmaceuticals' Short-term Investments tumbled by 8231.65% in 2024 and then surged by 82457.26% in 2025.
  • Day One Biopharmaceuticals' Short-term Investments (Quarter) stood at $257.0 million in 2022, then crashed by 47.25% to $135.6 million in 2023, then skyrocketed by 200.05% to $406.8 million in 2024, then grew by 0.38% to $408.3 million in 2025.
  • Its Short-term Investments stands at $408.3 million for Q3 2025, versus $417.5 million for Q2 2025 and $439.7 million for Q1 2025.